Shortage Watch Free FDA drug-shortage watch

← all medications

Podophyllum Resin Topical Tincture

Brand names: Podocon 25

Category: Dermatology

Not specified 1

FDA status: To Be Discontinued · Last FDA update: Jul 23, 2026 · First posted: Jul 23, 2026 · 1 manufacturers, 1 listed presentations

As of Jul 23, 2026, the FDA lists Podophyllum Resin Topical Tincture as being discontinued. Of 1 manufacturer presentations, 1 Not specified.

Ask your pharmacist: which of the 1 manufacturers below can they order right now, and whether a different strength or form of Podophyllum Resin Topical Tincture is available. For alternatives, talk to your prescriber — see what to do if your medication is in shortage.
Presentation & package NDCManufacturerAvailabilityFDA note
Podocon 25, Topical Tincture, 1 mg/4 mL (NDC 0574-0601-15)
NDC 0574-0601-15
Padagis US LLC Not specified Discontinuation of the manufacture of the drug

Related medications in shortage

Other Dermatology medications currently on the FDA shortage list — useful context if you and your prescriber are weighing alternatives. Always confirm with your pharmacist.

Change log

No changes recorded yet.
Tracking began Oct 1, 2026. We check the FDA every 6 hours; any real change - a manufacturer moving from Limited to Available, a new recovery date, a new listing - shows up here with its date.

Cite this: “FDA drug-shortage status for Podophyllum Resin Topical Tincture (FDA data as of Jul 23, 2026). Shortage Watch, openFDA.”

Get an email when this record changes

One email, only when the FDA changes something for Podophyllum Resin Topical Tincture. You confirm by clicking a link first (double opt-in). No newsletter, no other mail.

Check your inbox - click the confirmation link to activate alerts for Podophyllum Resin Topical Tincture.

Feeds instead of email: RSS or JSON. Unsubscribe anytime; see Privacy.

Embed a live status badge: /badge/podophyllum-resin-topical-tincture.svg

FDA data last synced Oct 1, 2026 (FDA record dated Sep 30, 2026).